Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1703

1.

Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease.

Maarouf M, Wickenheiser M, Krase JM, Wolter S, Shi VY.

Pediatr Dermatol. 2018 Nov;35(6):e391-e392. doi: 10.1111/pde.13607. Epub 2018 Sep 6.

PMID:
30187970
2.

[Severe hypoxemic respiratory failure caused by Pneumocystis jirovecii in a late kidney transplant recipient].

Nieto-Ríos JF, Zuluaga-Quintero M, Aristizábal-Alzate A, Ocampo-Kohn C, Serna-Higuita LM, Ramírez-Sánchez IC, Zuluaga-Valencia GA.

Biomedica. 2018 Mar 15;38(1):32-36. doi: 10.7705/biomedica.v38i0.3589. Spanish.

3.

Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis.

Tashiro H, Takahashi K, Kusaba K, Tanaka M, Komiya K, Nakamura T, Aoki Y, Kimura S, Sueoka-Aragane N.

Respir Investig. 2018 Mar;56(2):166-172. doi: 10.1016/j.resinv.2017.11.008. Epub 2018 Feb 22.

PMID:
29548655
4.

A case of probable trimethoprim-sulfamethoxazole induced circulating antineutrophil cytoplasmic antibody-positive small vessel vasculitis.

Woodring T, Abraham R, Frisch S.

Dermatol Online J. 2017 Aug 15;23(8). pii: 13030/qt3j9537pg.

PMID:
29469750
5.

Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.

Baltazard T, Dhaille F, Duvert-Lehembre S, Lok C, Chaby G.

Dermatol Online J. 2017 Aug 15;23(8). pii: 13030/qt9gv0j00w.

PMID:
29469749
6.

Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.

Crellin E, Mansfield KE, Leyrat C, Nitsch D, Douglas IJ, Root A, Williamson E, Smeeth L, Tomlinson LA.

BMJ. 2018 Feb 9;360:k341. doi: 10.1136/bmj.k341.

7.

[A Survey of the Adverse Effects and Influence of Concomitant Drugs for Methotrexate Intrathecal Administration].

Uchiyama M, Ueno M, Takamatsu Y, Matsuo K, Imakyure O, Kamimura H.

Yakugaku Zasshi. 2018;138(1):111-115. doi: 10.1248/yakushi.17-00122. Japanese.

8.

Persistent and severe hypoglycemia associated with trimethoprim-sulfamethoxazole in a frail diabetic man on polypharmacy: A case report and literature review
.

Rossio R, Arcudi S, Peyvandi F, Piconi S.

Int J Clin Pharmacol Ther. 2018 Feb;56(2):86-89. doi: 10.5414/CP203084. Review.

PMID:
29191263
9.

Possible Trimethoprim-Sulfamethoxazole-Induced Hemolytic Anemia: A Case Report.

Williams MF, Doss EP, Montgomery M.

J Pharm Pract. 2017 Dec;30(6):653-657. doi: 10.1177/0897190016683303. Epub 2016 Dec 14.

PMID:
29121838
10.

Trimethoprim-Sulfamethoxazole-Induced Drug Eruption With Eosinophilia and Systemic Symptoms (DRESS).

Antia C, Persad L, Alikhan A.

J Drugs Dermatol. 2017 Oct 1;16(10):1043-1046.

PMID:
29036260
11.

Cotrimoxazole-induced Methemoglobinemia.

Radhakrishnan N, Rai R.

Indian Pediatr. 2017 Sep 15;54(9):786-787. No abstract available.

PMID:
28984267
12.

Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.

Pokharel S, Basnyat B, Arjyal A, Mahat SP, Kc RK, Bhuju A, Poudyal B, Kestelyn E, Shrestha R, Phuong DNT, Thapa R, Karki M, Dongol S, Karkey A, Wolbers M, Baker S, Thwaites G.

Trials. 2017 Oct 2;18(1):450. doi: 10.1186/s13063-017-2199-6.

13.

Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.

Ewing AC, King CC, Wiener JB, Chasela CS, Hudgens MG, Kamwendo D, Tegha G, Hosseinipour MC, Jamieson DJ, Van der Horst C, Kourtis AP.

AIDS. 2017 Nov 28;31(18):2455-2463. doi: 10.1097/QAD.0000000000001641.

PMID:
28926409
14.

Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.

Lu YM, Lee YT, Chang HC, Yang HS, Chang CY, Huang CM, Wei J.

Transplant Proc. 2017 Oct;49(8):1893-1898. doi: 10.1016/j.transproceed.2017.04.020.

PMID:
28923644
15.

The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.

Linnik YA, Tsui EW, Martin IW, Szczepiorkowski ZM, Denomme GA, Gottschall JL, Hill JM Jr, Dunbar NM.

Transfusion. 2017 Dec;57(12):2937-2941. doi: 10.1111/trf.14315. Epub 2017 Sep 14.

PMID:
28905389
16.

A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.

Kosaka M, Ushiki A, Ikuyama Y, Hirai K, Matsuo A, Hachiya T, Hanaoka M.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01173-17. doi: 10.1128/AAC.01173-17. Print 2017 Dec.

17.

Isoniazid for preventing tuberculosis in HIV-infected children.

Zunza M, Gray DM, Young T, Cotton M, Zar HJ.

Cochrane Database Syst Rev. 2017 Aug 29;8:CD006418. doi: 10.1002/14651858.CD006418.pub3. Review.

18.

A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.

Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF; DMID 07-0051 Team.

N Engl J Med. 2017 Jun 29;376(26):2545-2555. doi: 10.1056/NEJMoa1607033.

19.

Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial.

Moran GJ, Krishnadasan A, Mower WR, Abrahamian FM, LoVecchio F, Steele MT, Rothman RE, Karras DJ, Hoagland R, Pettibone S, Talan DA.

JAMA. 2017 May 23;317(20):2088-2096. doi: 10.1001/jama.2017.5653.

20.

Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole.

Powers A, Loesch EB, Weiland A, Fioravanti N, Lucius D.

J Thromb Thrombolysis. 2017 Jul;44(1):88-93. doi: 10.1007/s11239-017-1497-x.

PMID:
28417267

Supplemental Content

Loading ...
Support Center